We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
The demand for reference drugs or so-called comparators is soaring as the volume, size and complexity of clinical trials reach record levels.
Having the product and patient insert printed in the local language for open label studies, a simpler clinical trial application and a faster supply are only three examples of local sourcing advantages.
This whitepaper will help you understand: